Like other regulatory frameworks, controlled substance compliance continues to evolve in response to changes in healthcare and public safety. These shifts impact every part of the controlled substance supply chain, including manufacturers, wholesalers, pharmacies, and the patients they serve. As a result, each year brings new compliance developments that directly and indirectly shape pharmacy workflows. This raises an important question: how can pharmacists not only keep up with these changes, but also adapt their already demanding operations to meet them?

This post offers a broad pharmacy outlook for 2026, highlighting key regulatory updates such as changes to the CSA, the rollout of DSCSA enforcement for smaller dispensers, and upcoming HIPAA requirements. It also explores emerging trends and practical strategies to help pharmacies stay compliant and prepared for the year ahead. With thoughtful planning and the right tools, pharmacies can navigate these changes with confidence while maintaining a safe, efficient, and compliant environment for both patients and staff. Read More >